HK1257591A1 - 預防和治療病理性腎組織損傷的藥物及其用途 - Google Patents

預防和治療病理性腎組織損傷的藥物及其用途

Info

Publication number
HK1257591A1
HK1257591A1 HK18116710.5A HK18116710A HK1257591A1 HK 1257591 A1 HK1257591 A1 HK 1257591A1 HK 18116710 A HK18116710 A HK 18116710A HK 1257591 A1 HK1257591 A1 HK 1257591A1
Authority
HK
Hong Kong
Prior art keywords
medicine
preventing
tissue damage
kidney tissue
treating pathologic
Prior art date
Application number
HK18116710.5A
Other languages
English (en)
Inventor
李季男
Original Assignee
深圳瑞健生命科學研究院有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳瑞健生命科學研究院有限公司 filed Critical 深圳瑞健生命科學研究院有限公司
Publication of HK1257591A1 publication Critical patent/HK1257591A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18116710.5A 2016-12-15 2018-12-28 預防和治療病理性腎組織損傷的藥物及其用途 HK1257591A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201611162257 2016-12-15
CN201611162270 2016-12-15

Publications (1)

Publication Number Publication Date
HK1257591A1 true HK1257591A1 (zh) 2019-10-25

Family

ID=62658161

Family Applications (3)

Application Number Title Priority Date Filing Date
HK18116705.2A HK1257586A1 (zh) 2016-12-15 2018-12-28 預防和治療腎纖維化的藥物及其用途
HK18116709.8A HK1257590A1 (zh) 2016-12-15 2018-12-28 預防和治療藥物性腎損傷的藥物及其用途
HK18116710.5A HK1257591A1 (zh) 2016-12-15 2018-12-28 預防和治療病理性腎組織損傷的藥物及其用途

Family Applications Before (2)

Application Number Title Priority Date Filing Date
HK18116705.2A HK1257586A1 (zh) 2016-12-15 2018-12-28 預防和治療腎纖維化的藥物及其用途
HK18116709.8A HK1257590A1 (zh) 2016-12-15 2018-12-28 預防和治療藥物性腎損傷的藥物及其用途

Country Status (2)

Country Link
CN (3) CN108210893A (zh)
HK (3) HK1257586A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201902419D0 (en) * 2019-02-22 2019-04-10 Singapore Health Serv Pte Ltd Treatment of kidney injury
CN115551534A (zh) * 2020-02-26 2022-12-30 泰伦基国际有限公司 一种预防和治疗血压异常病症的方法和药物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3153863B1 (en) * 2009-11-07 2020-04-01 Astute Medical, Inc. Methods and uses for evaluation of acute renal failure/acute renal injury

Also Published As

Publication number Publication date
HK1257590A1 (zh) 2019-10-25
HK1257586A1 (zh) 2019-10-25
CN108210894A (zh) 2018-06-29
CN108210893A (zh) 2018-06-29
CN108210908A (zh) 2018-06-29

Similar Documents

Publication Publication Date Title
IL272948B1 (en) enpp1 inhibitors and their use for cancer treatment
ZA201607415B (en) Antibody-drug-conjugate and its use for the treatment of cancer
EP3551100A4 (en) MEDICAL DEVICES FOR TREATING HARD TISSUES AND RELATED PROCESSES
ZA201908165B (en) Compounds for the prevention and treatment of diseases and the use thereof
HUE043640T2 (hu) Készülék és annak alkalmazása fluidumok UV-kezelésére
HK1257239A1 (zh) 預防和治療肥胖症的藥物及其用途
IL247586A0 (en) Use of Aribolin and mtor inhibitors as a combined treatment for cancer
HK1257589A1 (zh) 預防和治療組織器官纖維化的藥物及其用途
GB201519557D0 (en) Compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions
IL271878A (en) Use of wx-uk1 and its prodrug, wx-671, for the treatment of non-cancerous medical conditions
IL265824A (en) Methods and pharmaceutical compositions for the treatment of kidney cancer
EP3723742C0 (fr) Utilisation de la fluoroethylnormemantine pour la prevention et le traitement de l'anxiete
HK1257591A1 (zh) 預防和治療病理性腎組織損傷的藥物及其用途
HK1257238A1 (zh) 預防和治療脂質腎損傷的藥物及其用途
IL269121A (en) Usl-311 for use in the treatment of cancer
GB201522329D0 (en) Use of adjuvants for the prevention and/or treatment of autoimmune diseases
IL251407B (en) A multivalent compound for the treatment and prevention of brain damage
EP3400025C0 (en) USE OF GAIACOL FOR THE PREVENTION AND TREATMENT OF GLYCOGENOSES
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
IL273863A (en) Hemorrhoid treatment device
EP3648789C0 (en) MTMR2-S POLYPEPTIDE FOR USE IN THE TREATMENT OF MYOPATHY
RS65225B1 (sr) Lek za lečenje i/ili prevenciju endometrioze
EP3250558A4 (en) Hypdh inhibitors and methods of use for the treatment of kidney stones